•
|
Continued supporting software
development for InnovizOne deployment on BMW 5 Series in China – Innoviz is working closely with the BMW and Magna teams as they perform on-road testing and the Company is supporting software development specific to the Chinese
market for a new deployment of the InnovizOne on BMW 5 Series vehicles in China.
|
•
|
Working on program expansion
opportunities through collaboration with Mobileye and Volkswagen Group – In addition to the level 3 Cariad program, ID. Buzz long-range LiDAR, Innoviz is working on another level 3 program expansion through its collaboration
with the Volkswagen Group and Mobileye. In parallel, Innoviz continued commercial discussions with the Volkswagen Group regarding additional opportunities.
|
•
|
Progressing collaborations with
additional partners - Innoviz is working with the Qualcomm platform for the Volkswagen Cariad level 3 program and with the
Mobileye platform for the ID. Buzz program and the additional level 3 program. The Company continues to progress its collaboration with Nvidia and is working with OEMs on several Nvidia based RFQs in its pipeline.
|
•
|
Advancing pipeline
opportunities with two leading level 4 platform companies – The companies are in the trucking and ride hailing spaces and are working with various OEMs.
|
•
|
Reached key milestone with
successful winter test of InnovizTwo B-Sample with Volkswagen – The InnovizTwo late-stage B-sample was strenuously tested over 18 days of driving in harsh winter conditions across ten countries. InnovizTwo showed resilience to
different potential blockages and weather conditions, which we believe may provide the Company with a potential competitive advantage. The data and insights accumulated during the testing are being used to improve Innoviz's proprietary
AI-backed software and hardware solutions.
|
•
|
Successfully implemented
strategic realignment – The Company implemented nearly all of the initiatives of its previously announced realignment plan during the quarter.
|
•
|
Secure 2-3 additional customer programs in 2024
|
•
|
Secure $20-70 million of new NRE bookings in 2024
|
Three Months Ended
March 31,
|
||||||||
2024
|
2023
|
|||||||
Revenues
|
$
|
7,057
|
$
|
1,010
|
||||
Cost of revenues
|
(8,354
|
)
|
(4,941
|
)
|
||||
Gross loss
|
(1,297
|
)
|
(3,931
|
)
|
||||
Operating expenses:
|
||||||||
Research and development
|
23,845
|
26,102
|
||||||
Sales and marketing
|
2,400
|
2,448
|
||||||
General and administrative
|
5,444
|
4,735
|
||||||
Total operating expenses
|
31,689
|
33,285
|
||||||
Operating loss
|
(32,986
|
)
|
(37,216
|
)
|
||||
Financial income, net
|
2,901
|
2,776
|
||||||
Loss before taxes on income
|
(30,085
|
)
|
(34,440
|
)
|
||||
Taxes on income
|
(53
|
)
|
(360
|
)
|
||||
Net loss
|
$
|
(30,138
|
)
|
$
|
(34,800
|
)
|
||
Basic and diluted net loss per ordinary share
|
$
|
(0.18
|
)
|
$
|
(0.26
|
)
|
||
Weighted average number of ordinary shares used in computing basic and diluted net loss per ordinary share
|
165,666,183
|
136,358,385
|
March 31,
|
December 31,
|
|||||||
2024
|
2023
|
|||||||
(Unaudited)
|
(Audited)
|
|||||||
ASSETS
|
||||||||
CURRENT ASSETS:
|
||||||||
Cash and cash equivalents
|
$
|
14,271
|
$
|
26,283
|
||||
Short term restricted cash
|
53
|
53
|
||||||
Bank deposits
|
95,633
|
105,750
|
||||||
Marketable securities
|
13,543
|
13,335
|
||||||
Trade receivables, net
|
337
|
7,395
|
||||||
Inventory
|
2,012
|
1,868
|
||||||
Prepaid expenses and other current assets
|
2,277
|
5,774
|
||||||
Total current assets
|
128,126
|
160,458
|
||||||
LONG-TERM ASSETS:
|
||||||||
Marketable securities
|
4,806
|
4,813
|
||||||
Restricted deposits
|
2,566
|
2,623
|
||||||
Property and equipment, net
|
24,357
|
25,770
|
||||||
Operating lease right-of-use assets, net
|
24,926
|
25,486
|
||||||
Other long-term assets
|
82
|
84
|
||||||
Total long-term assets
|
56,737
|
58,776
|
||||||
Total assets
|
$
|
184,863
|
$
|
219,234
|
||||
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
CURRENT LIABILITIES:
|
||||||||
Trade payables
|
$
|
5,043
|
$
|
8,036
|
||||
Deferred revenues
|
582
|
6,949
|
||||||
Employees and payroll accruals
|
10,252
|
9,468
|
||||||
Accrued expenses and other current liabilities
|
8,192
|
8,743
|
||||||
Operating lease liabilities
|
4,054
|
4,034
|
||||||
Total current liabilities
|
28,123
|
37,230
|
||||||
LONG-TERM LIABILITIES:
|
||||||||
Operating lease liabilities
|
27,315
|
28,475
|
||||||
Warrants liability
|
154
|
240
|
||||||
Total long-term liabilities
|
27,469
|
28,715
|
||||||
SHAREHOLDERS' EQUITY:
|
||||||||
Ordinary Shares of no-par value
|
-
|
-
|
||||||
Additional paid-in capital
|
794,697
|
788,577
|
||||||
Accumulated deficit
|
(665,426
|
)
|
(635,288
|
)
|
||||
Total shareholders' equity
|
129,271
|
153,289
|
||||||
Total liabilities and shareholders' equity
|
$
|
184,863
|
$
|
219,234
|
Three Months Ended
March 31,
|
||||||||
2024
|
2023
|
|||||||
Cash flows from operating activities:
|
||||||||
Net loss
|
$
|
(30,138
|
)
|
$
|
(34,800
|
)
|
||
Adjustments required to reconcile net loss to net cash used in
operating activities:
|
||||||||
Depreciation and amortization
|
2,495
|
1,407
|
||||||
Remeasurement of warrants liability
|
(86
|
)
|
-
|
|||||
Change in accrued interest on bank deposits
|
(787
|
)
|
1,195
|
|||||
Change in marketable securities
|
(158
|
)
|
(294
|
)
|
||||
Share-based compensation
|
6,510
|
5,300
|
||||||
Foreign exchange gain, net
|
(46
|
)
|
(89
|
)
|
||||
Change in prepaid expenses and other assets
|
2,170
|
424
|
||||||
Change in trade receivables, net
|
7,058
|
(292
|
)
|
|||||
Change in inventory
|
(144
|
)
|
103
|
|||||
Changes in operating lease assets and liabilities, net
|
(580
|
)
|
33
|
|||||
Change in trade payables
|
(2,067
|
)
|
(1,346
|
)
|
||||
Change in accrued expenses and other liabilities
|
(835
|
)
|
762
|
|||||
Change in employees and payroll accruals
|
1,106
|
779
|
||||||
Change in deferred revenues
|
(6,367
|
)
|
219
|
|||||
Net cash used in operating activities
|
(21,869
|
)
|
(26,599
|
)
|
||||
Cash flows from investing activities:
|
||||||||
Purchase of property and equipment
|
(1,149
|
)
|
(2,357
|
)
|
||||
Investment in bank deposits
|
(14,000
|
)
|
-
|
|||||
Withdrawal of bank deposits
|
25,000
|
79,500
|
||||||
Investment in restricted deposits
|
(67
|
)
|
(40
|
)
|
||||
Investment in marketable securities
|
(938
|
)
|
(7,100
|
)
|
||||
Proceeds from sales and maturities of marketable securities
|
895
|
13,830
|
||||||
Net cash provided by investing activities
|
9,741
|
83,833
|
||||||
Cash flows from financing activities:
|
||||||||
Proceeds from exercise of options
|
42
|
120
|
||||||
Net cash provided by financing activities
|
42
|
120
|
||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
74
|
126
|
||||||
Increase (decrease) in cash, cash equivalents and restricted cash
|
(12,012
|
)
|
57,480
|
|||||
Cash, cash equivalents and restricted cash at the beginning of the period
|
26,336
|
55,954
|
||||||
Cash, cash equivalents and restricted cash at the end of the period
|
$
|
14,324
|
$
|
113,434
|